Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing surgical conditions with deep neuromuscular blockade during gynecologic laparoscopy
2013-001164-29Phase 4Completed
- Sponsor
- Department of anesthesiology
- Start
- May 2013
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Sugammadex and rocuronium in gynaecological conditions (2 arms), sponsored by Department of anesthesiology. Primary endpoint: Intraabdominal distance at 12 mmHg with and without deep neuromuscular blockade. Started May 2013; status: completed.
02
Drugs
Sugammadexrocuronium
03
Conditions
gynaecological conditions
Beyond the preview
Go deeper on 2013-001164-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001164-29.